LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling
Roland Christian Schelker(University Hospital Regensburg), Luca Gattinoni(National Cancer Institute)
Cited by 17
Related Papers
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
|Journal of Clinical Investigation|2005|949
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
|Journal of Clinical Investigation|2013|930
Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection
|The Journal of Experimental Medicine|2015|258